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Purpose: To investigate the consequence of a major intrinsic protein MIP splice-site mutation (c.607–1G>A) in a four-
generation Chinese pedigree afflicted with autosomal dominant congenital cataracts (ADCC).
Methods:  Both  a  mutated  minigene  with  c.607–1G>A,  and  a  wild-type  minigene  were  constructed  using  the
pTARGETTM mammalian expression vector. They were transiently transfected into HeLa cells and human lens epithelial
cells, respectively. After 48 h incubation, RNA extraction and RT–PCR analysis were performed and PCR products were
separated and confirmed by sequencing. Structural models of the wild-type and the mutant aquaporin 0 (AQP0) were
generated and analyzed using SWISS-MODEL.
Results: The G>A transition activated a cryptic acceptor splice site (c.965–966) in the 3′ untranslated region (3′ UTR),
resulting in the absence of the coding region and most of the 3′UTR in exon 4 of the mature mRNA. Moreover, homology
modeling of the mutant protein suggested that the sixth transmembrane helix and carboxyl terminus were replaced with
the Leu-His-Ser tripeptide (AQP0-LHS).
Conclusions: The MIP splice-site mutation (c.607–1G>A) activates a cryptic acceptor splice site in the 3′ UTR, which
may result in substitution of the sixth transmembrane helix and carboxyl terminus for AQP0-LHS. To our knowledge,
this is the first report of activation of a cryptic splice site in the 3′ UTR in a human disease gene.
Hereditary  congenital  cataract  (OMIM  604307)  is  an
opacification of the eye lens which presents at birth or shortly
thereafter. Despite the great advances in understanding of lens
structure  and  function,  the  relationships  among  cataract
morphology, etiology, and pathologic mechanisms are still
unclear.  Congenital  cataracts  remain  the  leading  cause  of
visual disability in children worldwide [1-4]. In 2000, the
major intrinsic protein (MIP, MP26, AQP0) was reported to
be associated with autosomal dominant congenital cataract
(ADCC) [5]. To date, seven mutations in the MIP gene have
been identified from seven unrelated human families; five
missense  mutations  (T138R,  E134G,  R33C,  R233K,  and
V107I) [5-8], one deletion mutation causing a frameshift that
alters 41 of 45 subsequent amino acids and creates a premature
stop codon (G213VfsX45) [9], and one splice-site mutation
causing  autosomal  dominant  congenital  cataract  (ADCC)
with “snail-like” phenotype in a large Chinese family (our
laboratory’s recently reported finding, c.607–1G>A) [10].
The effect of mutations that alter critical amino acids and
generate premature stop codons can be predicted from triplet
codon analysis. However, it is difficult to predict the effects
of changes in intronic sequences. The production of mature
mRNA requires an accurate and efficient removal of introns
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from pre-mRNA by the spliceosome [11]. The regulation of
alternative splicing usually relies on a choice from among
candidate splice sites, either alternative 5′ or alternative 3′
sites. Mutations can disrupt splicing by directly inactivating
or creating an alternative splicing site, by activating a cryptic
splice site or by interfering with splicing regulatory elements.
Although  the  activation  of  cryptic  splice  sites  has  been
reported as a mechanism in human disease, to the best of our
knowledge currently there is no report of activation of cryptic
splice site in the 3′ untranslated region (3′ UTR, sequences on
the 3′ end of mRNA which are not translated into protein)
[12].
METHODS
Plasmid and minigene constructs: A mutated minigene was
obtained by the insertion of a PCR fragment containing the
genomic  MIP  sequence  from  the  proband  into  the
pTARGETTM  mammalian  expression  vector  (Promega,
Milan, Italy). It consisted of the 5′ flanking sequence of exon
3, exon 3, intron 3, and exon 4 including the coding and the
3-untranslated region (3′UTR) which was amplified using
primers MIPS (5′-TTG ACC CCA AGG TAG AAA TGA
CG-3′) and MIPAS (5′-ACA ATC AGC ACA CAC GGC
GAA G-3′). PCR was performed on 100 μg genomic DNA in
a standard 50 μl volume, containing 1.25 PrimeSTAR® HS
DNA  Polymerase  (Takara  Bio,  Otsu,  Japan).  The  cycling
conditions for PCR were 35 cycles of 98 °C for 10 s, 68 °C
for 4 min, preceded by 30 s at 98 °C and followed by a final
elongation step at 68 °C for 10 min. The PCR product was
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2253cloned into the vector after the addition of an A-tail (Figure
1). The addition of the A-tail was achieved by incubating
5 μl purified PCR product in a 10 μl volume, containing dATP
(final concentration 0.2 mM) and 5 U Taq DNA Polymerase
(Takara Bio), The temperature condition was at 70 °C for 30
min.  Plasmid  DNA  was  isolated  using  a  Miniprep  Kit
(Axygene,  Union  City,  CA)  and  MIP  c.607–1G>A  was
ascertained  by  sequencing—pTARGET-mut.  A  similar
approach was used to obtain the corresponding wild type
minigene by amplifying the genomic DNA from a healthy
individual—pTARGET-wt.  Each  clone  was  entirely
sequenced  to  confirm  that  no  other  mutations  had  been
introduced by the PCR procedure.
Cell culture and transient transfection: HeLa cells and human
lens epithelial cells (LECs, HLE B-3) were cultured in RPMI
1640 supplemented with 10% fetal bovine serum. Cells were
grown in a humidified atmosphere of 5% CO2 and 95% air at
37  °C  and  cultured  according  to  standard  procedures.
Transient  transfections  were  performed  in  10-cm  dishes
(2×106cells/dish)  with  Lipofectamine™  2000  (Invitrogen,
Carlsbad, CA) using 4 µg of total plasmid DNA Endofree
purified  (Qiagen,  Hilden,  Germany)  following  the
manufacturer’s instructions.
Minigene splicing assay: Both HeLa cell and LECs were
transfected with pTARGET-mut and pTARGET-wt minigene
constructs. The blank minigene construct pTARGET-con was
used as a control. Forty-eight hours after transfection, total
RNA from the cells was extracted with an RNeasy Mini Kit
(Qiagen) and analyzed by RT–PCR. Reverse transcription
was  performed  using  M-MuLV  reverse  transcriptase
(Fermentas, Vilnius, Lithuania) and oligo (dT) primer in a
20 μl volume according to the protocol of the manufacturer,
and the PCR reaction was performed with a forward primer
(5′-CTT TGC TCC TGC CAT TCT-3′) and a vector-specific
reverse primer (5′-GGC TTT ACA CTT TAT GCT TC-3′).
PCR products were separated by electrophoresis on a 2%
agarose gels and confirmed by sequencing.
Comparative  modeling  of  AQP0:  The  three-dimensional
structure of AQP0 was modeled on the basis of the crystal
structure  of  bovine  AQP0.  The  homology  model  was
generated by SWISS-MODEL and analyzed in the Swiss-
PdbViewer, Version 3.7 [13-15].
RESULTS
Effect of the intronic mutation on the processing of the pre-
mRNA transcript: Figure 2 showed the results when plasmids,
pTARGET-mut,  pTARGET-wt,  and  pTARGET-con  were
independently  transfected  to  HeLa  cells  and  LECs  (not
expressing  AQP0),  and  total  RNA  was  extracted  from
transfected  cells  and  analyzed  by  RT–PCR  followed  by
electrophoresis on 2% agarose gels. RT–PCR of the total RNA
obtained from cells transfected by pTARGET-wt yielded a
687  bp  band  consistent  with  the  correct  splicing  of  pre-
mRNA. This was confirmed by sequencing of the isolated
PCR product (Figure 3A). In contrast, a 327 bp band was
detected in cells transfected with pTARGET-mut (Figure 2)
and the sequencing analysis shown in Figure 3B demonstrated
that a cryptic acceptor splice site was activated at nt359 of
exon 4 (c.965–966) in the 3′UTR of the MIP gene. A summary
of these results was shown in Figure 4.
Comparison  of  wild-type  and  mutant  AQP0  structural
models: A mutant protein with 205 amino acids was supposed
to be generated when the cryptic splice site in the 3′ UTR was
activated.  Wild-type  AQP0  structural  model  contains  six
transmembrane α-helical domains with a short 9 amino acid
NH2-terminus and a longer 39 amino acid COOH-terminus
extending  into  the  cytoplasm,  whereas  the  mutant  AQP0
structural model showed the loss of the last α-helical domain
as well as the complete COOH-terminus. Instead, the aberrant
AQP0 model (AQP0-LHS) was ended up having the Leu-His-
Ser tripeptide (Figure 5).
Figure  1.  Schematic  diagram  of  the
minigene construct. It was obtained by
insertion of a PCR fragment containing
the  genomic  MIP  sequence  into  the
pTARGET  mammalian  expression
vector  after  the  A-tail  was  added.  It
consists of the 5′ flanking sequence of
exon 3, exon 3, intron 3, and exon 4
including  the  coding  and  the  3-
untranslated region (3′UTR) which was
amplified  using  primers  MIPS  and
MIPAS.
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It is reported that mutations in acceptor splice sites can result
in exon skipping or activation of cryptic sites, either upstream
or downstream of authentic sites [16]. In the present study,
there was a mutation in the invariant AG dinucleotide of the
last  intron,  so  none  of  the  existing  canonical  AG  sites
downstream are available at the 5′ border of following exon
as an alternative acceptor splice site. According to previous
studies, it is advisable to identify possible splicing defects by
analyzing the mRNA available from the individual patients
[17].  Therefore,  we  collected  blood  specimens  and  the
cataracts  from  the  proband  during  surgery.  However,  we
failed to extract MIP mRNA from the blood specimens or the
cataract probably due to the lower mRNA expression levels
in the mutant alleles (unpublished). To confirm the role of this
mutation, we finally made use of a simple minigene splicing
assay [18]. Subsequently, we demonstrated that the acceptor
splice-site mutation (c.607–1G>A) resulted in activation of a
cryptic splice site in the 3′ UTR of the MIP gene. To our
knowledge, cryptic acceptor splice site in the 3′ UTR has not
been reported in human disease genes to date (summery in
Table 1) [12,16]. According to Human Splicing Finder [19],
the natural acceptor splice site is scored 96.46, while the
cryptic acceptor splice site is scored 74.48. Interestingly, there
is a consensus motif (TCTTTC) upstream of the acceptor
splice site. Further study is required to determine whether
there is a role for the TCTTTC motif in the aberrant splicing.
The activation of a cryptic acceptor splice site may lead
to substitution of the distal end of the 6th trans-membrane
domain and the COOH-terminal domain of AQP0 for a Leu-
His-Ser  tripeptide  (AQP0-LHS).  Previous  studies  have
Figure  2.  RT–PCR  products  obtained
from  minigene  constructs  transient
transfection. The mutated (pTARGET-
mut)  and  wild-type  (pTARGET-wt)
minigene  constructs  were
independently  transfected  into  HeLa
cells  and  human  lens  epithelial  cells
(LECs).  Forty-eight  hours  later,  total
RNA  was  extracted  from  transfected
cells  and  analyzed  by  RT–PCR.  The
RT–PCR  product  obtained  from
pTARGET-wt  and  pTARGET-mut
shows a 687 bp band and a 327 bp band,
respectively. The pTARGET-col used
as a control shows a negative band.
Figure 3. Reverse sequence of the wild-
type and the mutant RT–PCR products.
A:  Normal  splicing  shows  the  exact
excision  of  intron  3.  B:  Aberrant
splicing shows the activation of a cryptic
splice acceptor site within the 3′ UTR of
the MIP gene, resulting in the loss of the
coding  region  and  most  of  the
untranslated region of exon 4.
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both  lens  development  and  transparency  because  of  its
interactions with calmodulin [20], the cytoskeletal proteins
filensin and CP49 [21], and connexin 45.6 [22]. Cleavage of
the  intracellular  COOH-terminus  decreases  water
permeability [23] and enhances the adhesive properties of the
extracellular surface of AQP0, indicating a conformational
change in the molecule [24] such that AQP0-LHS may fail to
form  a  functional  channel.  As  a  result,  the  internal
homeostasis of the lens necessary to maintain transparency is
disrupted, resulting in cataract formation.
In conclusion, analysis using an in vitro minigene system
demonstrates that the MIP c.607–1G>A mutation leads to
aberrant splicing by activation of a cryptic acceptor splice site
in the 3′ UTR of the MIP gene. To our knowledge, this is the
first report of cryptic acceptor splice site in the 3′ UTR of a
human disease gene. The c.607–1G>A mutation creates a de
novo  AQP0-LHS,  which  is  predicted  to  cause  congenital
cataracts by disrupting the internal homeostasis of the lens
fiber cells.
Figure  4.  Schematic  diagram  of
comparison  between  normal  splicing
and aberrant splicing. The upper panel
shows the normal splicing of the wild-
type RNA transcript. The lower panel
shows  that  the  G>A  mutation  (black
triangles) at the acceptor splice site of
intron 3 leads to activation of a cryptic
acceptor splice site within the 3′ UTR of
the MIP gene, resulting in the loss of the
coding  region  and  most  of  the
untranslated  region  of  exon  4.  The
underlining  codon  (UAG  and  uga)
denote  the  wild  type  and  de  novo
terminal  codon,  respectively.  The  61
amino  acids  encoded  by  exon  4  are
replaced by a Leu-His-Ser tripeptide.
Figure 5. Comparison of wild-type and
mutant  AQP0  structural  models  by
SWISS-MODEL.  A:  The  wild-type
AQP0  structural  model  contains  six
transmembrane α-helical domains with
a short 9 amino acid NH2-terminus and
a longer 39 amino acid COOH-terminus
extending into the cytoplasm. B: The
mutant AQP0 structural model shows
the absence of the last α-helical domain
as  well  as  the  complete  COOH-
terminus.
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